1. Home
  2. STXS vs FLC Comparison

STXS vs FLC Comparison

Compare STXS & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • FLC
  • Stock Information
  • Founded
  • STXS 1990
  • FLC 2003
  • Country
  • STXS United States
  • FLC United States
  • Employees
  • STXS N/A
  • FLC N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FLC Trusts Except Educational Religious and Charitable
  • Sector
  • STXS Health Care
  • FLC Finance
  • Exchange
  • STXS Nasdaq
  • FLC Nasdaq
  • Market Cap
  • STXS 151.3M
  • FLC 174.2M
  • IPO Year
  • STXS 2004
  • FLC N/A
  • Fundamental
  • Price
  • STXS $2.20
  • FLC $16.31
  • Analyst Decision
  • STXS
  • FLC
  • Analyst Count
  • STXS 0
  • FLC 0
  • Target Price
  • STXS N/A
  • FLC N/A
  • AVG Volume (30 Days)
  • STXS 288.7K
  • FLC 37.8K
  • Earning Date
  • STXS 08-11-2025
  • FLC 01-01-0001
  • Dividend Yield
  • STXS N/A
  • FLC 6.64%
  • EPS Growth
  • STXS N/A
  • FLC N/A
  • EPS
  • STXS N/A
  • FLC N/A
  • Revenue
  • STXS $27,510,000.00
  • FLC N/A
  • Revenue This Year
  • STXS $25.90
  • FLC N/A
  • Revenue Next Year
  • STXS $60.57
  • FLC N/A
  • P/E Ratio
  • STXS N/A
  • FLC N/A
  • Revenue Growth
  • STXS 1.50
  • FLC N/A
  • 52 Week Low
  • STXS $1.54
  • FLC $12.62
  • 52 Week High
  • STXS $2.72
  • FLC $15.45
  • Technical
  • Relative Strength Index (RSI)
  • STXS 52.17
  • FLC 67.52
  • Support Level
  • STXS $2.08
  • FLC $16.86
  • Resistance Level
  • STXS $2.36
  • FLC $16.90
  • Average True Range (ATR)
  • STXS 0.12
  • FLC 0.13
  • MACD
  • STXS -0.01
  • FLC 0.01
  • Stochastic Oscillator
  • STXS 55.56
  • FLC 92.68

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: